貝思生物科技有限公司
徐仲鍈 賽馬會公共衞生及基層醫療學院教授;研究及知識轉移服務處處長
王海天 賽馬會公共衞生及基層醫療學院副教授
曹莉蓉(18研究院流行病學與生物統計學); 研究院公共衛生博士生
樓靜致(18研究院流行病學與生物統計學)
陳思暘 (19聯合公共衞生)
李奇 研究院公共衛生博士生
趙時 研究院公共衛生博士生
鄭泓 賽馬會公共衛生及基層醫療學院研究助理

項目簡介|PROJECT SUMMARY

Vaccine technology solutions and complex disease screening

發展階段|STAGE OF DEVELOPMENT

Ready to launch

產品特點|DISTINGUISHED FEATURES

Vaccine technologies empowered by bioinformatics, A.I and virology:

  • Viral genome mutation prediction
  • Region-specific antigen design
  • Codon optimization/optimization
  • Continuous innovation and new solutions
  • In co-development with multiple pharmaceutical companies

Complex disease screening using human genome data

  • Highly accurate to support clinical interpretation
  • Tolerates genome data of various format and quality
  • Cloud-based analysis respecting privacy
  • For Alzheimer’s Disease, Schizophrenia and more
  • Co-developing product with gene-testing company

如何解決市場痛點|RESPONSE TO MARKET PAIN POINTS

Vaccine effectiveness (VE) for a fast mutating virus such as Influenza, is highly affected by regional genetic mutations. Through characterizing these mutations, we could provide optimal antigen designs that improve VE for Influenza vaccines by 20-40%.. Furthermore, pharmaceutical companies face different technological bottlenecks when they try to develop their own vaccines. This is when our company’s solutions and research capabilities to constantly develop new technologies could help to overcome patent barriers and provide solutions.
For disease screening tests, accuracy makes all the difference. Our tests provide extra value for commercial gene-testing customers,
insurance companies, and could assist clinical interpretations.

現在尋找…|LOOKING FOR…

  • 資金 Funding
  • 創業夥伴 Partners
  • 曝光機會 Visibility and Exposure

公司網址|WEBSITE

www.bethbio.com

社交媒體|SOCIAL MEDIA

聯絡|CONTACT